Angiotensin receptor blockers (ARBs) vs angiotensin‐converting enzyme inhibitors (ACEis)
Death (all causes) · people with diabetes and kidney disease
Angiotensin receptor blockers showed no clear difference in all‐cause death Median compared with angiotensin‐converting‐enzyme inhibitors (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 1.13 [0.68, 1.88]15 studies · 1739 participantsLow